April 29th 2025
At Asembia’s AXS25 Summit, industry experts explored how pharmacy is evolving to meet rising patient expectations and navigate a shifting health care environment.
A Way Out of the Dismal Arithmetic of Hepatitis C Treatment
This special issue presents important new peer-reviewed research, covering issues ranging from access and the out-of-pocket costs of a treatment course, to the real-world consequences-both economic and clinical-of failing to treat.
Read More
Sofosbuvir Initial Therapy Abandonment and Manufacturer Coupons in a Commercially Insured Population
Member cost negatively affects initial medication adherence and manufacturer coupons can decrease member share by up to 98%.
Read More
Real-World Outcomes of Ledipasvir/Sofosbuvir in Treatment-Naïve Patients With Hepatitis C
In the treatment of hepatitis C virus, the gap between efficacy and real-world effectiveness narrows with improved tolerability and ease of use.
Read More
Costs for a Health Coaching Intervention for Chronic Care Management
On average, the health coach intervention cost $483 per participant per year. There was no evidence that the coaching intervention saved money at 1 year.
Read More